Plasma AR and abiraterone-resistant prostate cancer.

Romanel A, Gasi Tandefelt D, Conteduca V, Jayaram A, Casiraghi N, Wetterskog D, Salvi S, Amadori D, Zafeiriou Z, Rescigno P, Bianchini D, Gurioli G, Casadio V, Carreira S, Goodall J, Wingate A, Ferraldeschi R, Tunariu N, Flohr P, De Giorgi U, de Bono JS, Demichelis F, Attard G

Open source

DOI: 10.1126/scitranslmed.aac9511
Published: 2015 Nov 4
Container: Science translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.aac9511,
  title = {Plasma AR and abiraterone-resistant prostate cancer.},
  author = {Romanel A and Gasi Tandefelt D and Conteduca V and Jayaram A and Casiraghi N and Wetterskog D and Salvi S and Amadori D and Zafeiriou Z and Rescigno P and Bianchini D and Gurioli G and Casadio V and Carreira S and Goodall J and Wingate A and Ferraldeschi R and Tunariu N and Flohr P and De Giorgi U and de Bono JS and Demichelis F and Attard G},
  year = {2015},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.aac9511},
  url = {https://doi.org/10.1126/scitranslmed.aac9511}
}

RIS

TY  - JOUR
TI  - Plasma AR and abiraterone-resistant prostate cancer.
AU  - Romanel A
AU  - Gasi Tandefelt D
AU  - Conteduca V
AU  - Jayaram A
AU  - Casiraghi N
AU  - Wetterskog D
AU  - Salvi S
AU  - Amadori D
AU  - Zafeiriou Z
AU  - Rescigno P
AU  - Bianchini D
AU  - Gurioli G
AU  - Casadio V
AU  - Carreira S
AU  - Goodall J
AU  - Wingate A
AU  - Ferraldeschi R
AU  - Tunariu N
AU  - Flohr P
AU  - De Giorgi U
AU  - de Bono JS
AU  - Demichelis F
AU  - Attard G
PY  - 2015
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.aac9511
UR  - https://doi.org/10.1126/scitranslmed.aac9511
ER  -

APA

A, R., D, G. T., V, C., A, J., N, C., D, W., S, S., D, A., Z, Z., P, R., D, B., G, G., V, C., S, C., J, G., A, W., R, F., N, T., P, F., U, D. G., JS, D. B., F, D., & G, A. (2015). Plasma AR and abiraterone-resistant prostate cancer.. Science translational medicine. https://doi.org/10.1126/scitranslmed.aac9511

Source records

pubmed · retrieved 2026-09-27T00:35:31.935Z
europe-pmc · retrieved 2026-09-27T00:35:31.947Z